Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities

Stem Cell Research

Volumn 8, Issue 1, 2012, Pages 58-73

  Pelekanos, Rebecca A ^b,c,f   Li, Joan ^a,b   Gongora, Milena ^a,b   Chandrakanthan, Vashe ^b,d   Scown, Janelle ^a,b   Suhaimi, Norseha ^a,b   Brooke, Gary ^c   Christensen, Melinda E ^c   Doan, Tram ^d   Rice, Alison M ^c   Osborne, Geoffrey W ^a,b   Grimmond, Sean M ^a,b   Harvey, Richard P ^a,d,e   Atkinson, Kerry ^a,b,c   Little, Melissa H ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^d VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ATAXIN 1; B7 ANTIGEN; BETA1 INTEGRIN; BONE MORPHOGENETIC PROTEIN; CD24 ANTIGEN; CD51 ANTIGEN; ENDOGLIN; EPITOPE; FIBROBLAST GROWTH FACTOR 10; HEAT SHOCK PROTEIN 47; HERMES ANTIGEN; MACROPHAGE MIGRATION INHIBITION FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PIGMENT EPITHELIUM DERIVED FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; T BOX TRANSCRIPTION FACTOR; THY 1 ANTIGEN; THYMOSIN BETA10; TRANSCRIPTOME; ZYXIN;

ADIPOCYTE; ALLOIMMUNITY; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL NUCLEUS; CELL POPULATION; CELL PROLIFERATION; CELL SIZE; CELL STRUCTURE; CHROMATIN; COLONY FORMING CELL; COLONY FORMING UNIT F; COMPARATIVE STUDY; CYTOPLASM; EPITOPE MAPPING; GENE EXPRESSION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPHENOTYPING; IN VITRO STUDY; KIDNEY CELL; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MESODERM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE REPAIR; UPREGULATION;

ANIMALS; BONE MARROW CELLS; CELL SHAPE; COLONY-FORMING UNITS ASSAY; EPITOPES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; KIDNEY; MESENCHYMAL STEM CELLS; MICE; MYOCARDIUM; ORGAN SPECIFICITY; PLURIPOTENT STEM CELLS; RNA, MESSENGER; TRANSCRIPTOME;

MURINAE;

EID: 80052709751     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2011.08.003     Document Type: Article

References (70)

1. Barlow S., Brooke G., Chatterjee K., Price G., Pelekanos R., Rossetti T., Doody M., Venter D., Pain S., Gilshenan K., Atkinson K. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev. 2008, 17:1095-1107.
2. Barraud P., Stott S., Mollgard K., Parmar M., Bjorklund A. In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133. J. Neurosci. Res. 2007, 85:250-259.
3. Basson C.T., Bachinsky D.R., Lin R.C., Levi T., Elkins J.A., Soults J., Grayzel D., Kroumpouzou E., Traill T.A., Leblanc-Straceski J., Renault B., Kucherlapati R., Seidman J.G., Seidman C.E. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat. Genet. 1997, 15:30-35.
4. Bexell D., Gunnarsson S., Tormin A., Darabi A., Gisselsson D., Roybon L., Scheding S., Bengzon J. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol. Ther. 2009, 17:183-190.
5. Bianco P., Robey P.G., Simmons P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008, 2:313-319.
6. Brachvogel B., Moch H., Pausch F., Schlotzer-Schrehardt U., Hofmann C., Hallmann R., von der Mark K., Winkler T., Poschl E. Perivascular cells expressing annexin A5 define a novel mesenchymal stem cell-like population with the capacity to differentiate into multiple mesenchymal lineages. Development 2005, 132:2657-2668.
7. Cai J., Li W., Su H., Qin D., Yang J., Zhu F., Xu J., He W., Guo X., Labuda K., Peterbauer A., Wolbank S., Zhong M., Li Z., Wu W., So K.F., Redl H., Zeng L., Esteban M.A., Pei D. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J. Biol. Chem. 2010, 285:11227-11234.
8. Califano D., Monaco C., Santelli G., Giuliano A., Veronese M.L., Berlingieri M.T., de Franciscis V., Berger N., Trapasso F., Santoro M., Viglietto G., Fusco A. Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res. 1998, 58:823-828.
9. Caplan A.I. Mesenchymal stem cells. J. Orthop. Res. 1991, 9:641-650.
10. Christensen M.E., Turner B.E., Sinfield L.J., Cullup H., Kollar K., Waterhouse N.J., Hart D.N., Atkinson K., Rice A.M. Infusion of allogeneic mesenchymal stromal cells can delay but not prevent GVHD after murine transplantation. Haematologica 2010, 95:2102-2110.
11. Covas D.T., Panepucci R.A., Fontes A.M., Silva W.A., Orellana M.D., Freitas M.C., Neder L., Santos A.R., Peres L.C., Jamur M.C., Zago M.A. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp. Hematol. 2008, 36:642-654.
12. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P.N., Traas J., Schugar R., Deasy B.M., Badylak S., Buhring H.J., Giacobino J.P., Lazzari L., Huard J., Peault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
13. da Silva Meirelles L., Nardi N.B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br. J. Haematol. 2003, 123:702-711.
14. da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 2006, 119:2204-2213.
15. da Silva Meirelles L., Caplan A.I., Nardi N.B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008, 26:2287-2299.
16. Dodou E., Verzi M.P., Anderson J.P., Xu S.M., Black B.L. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 2004, 131:3931-3942.
17. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
18. Du P., Kibbe W.A., Lin S.M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24:1547-1548.
19. Ebihara Y., Masuya M., Larue A.C., Fleming P.A., Visconti R.P., Minamiguchi H., Drake C.J., Ogawa M. Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp. Hematol. 2006, 34:219-229.
20. Fraser J.K., Wulur I., Alfonso Z., Zhu M., Wheeler E.S. Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots. Cytotherapy 2007, 9:459-467.
21. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., Panasuk A.F., Rudakowa S.F., Luria E.A., Ruadkow I.A. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol. 1974, 2:83-92.
22. Greco S.J., Liu K., Rameshwar P. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 2007, 25:3143-3154.
23. Guillot P.V., Gotherstrom C., Chan J., Kurata H., Fisk N.M. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 2007, 25:646-654.
24. Guillot P.V., De Bari C., Dell'Accio F., Kurata H., Polak J., Fisk N.M. Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation 2008, 76:946-957.
25. Hoogduijn M.J., Crop M.J., Peeters A.M., Van Osch G.J., Balk A.H., Ijzermans J.N., Weimar W., Baan C.C. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev. 2007, 16:597-604.
26. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., Deans R.J., Krause D.S., Keating A. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393-395.
27. Huang C.M., Wang C.C., Barnes S., Elmets C.A. In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteomics. Proteomics 2006, 6:5805-5814.
28. Iop L., Chiavegato A., Callegari A., Bollini S., Piccoli M., Pozzobon M., Rossi C.A., Calamelli S., Chiavegato D., Gerosa G., De Coppi P., Sartore S. Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury. Cell Transplant. 2008, 17:679-694.
29. Jiang X.X., Su Y.F., Li X.S., Zhang Y., Wu Y., Mao N. Human fetal heart-derived adherent cells with characteristics similar to mesenchymal progenitor cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006, 14:1191-1194.
30. Kassem M., Kristiansen M., Abdallah B.M. Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin. Pharmacol. Toxicol. 2004, 95:209-214.
31. Kern S., Eichler H., Stoeve J., Kluter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
32. Kode J.A., Mukherjee S., Joglekar M.V., Hardikar A.A. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009, 11:377-391.
33. Kollar K., Cook M.M., Atkinson K., Brooke G. Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction. Int. J. Cell Biol. 2009, 2009:904682.
34. Lai R.C., Arslan F., Lee M.M., Sze N.S., Choo A., Chen T.S., Salto-Tellez M., Timmers L., Lee C.N., El Oakley R.M., Pasterkamp G., de Kleijn D.P., Lim S.K. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010, 4:214-222.
35. Lapteva N., Ando Y., Nieda M., Hohjoh H., Okai M., Kikuchi A., Dymshits G., Ishikawa Y., Juji T., Tokunaga K. Profiling of genes expressed in human monocytes and monocyte-derived dendritic cells using cDNA expression array. Br. J. Haematol. 2001, 114:191-197.
36. Lee S.H., Son M.J., Oh S.H., Rho S.B., Park K., Kim Y.J., Park M.S., Lee J.H. Thymosin {beta}(10) inhibits angiogenesis and tumor growth by interfering with Ras function. Cancer Res. 2005, 65:137-148.
37. Lengner C.J., Camargo F.D., Hochedlinger K., Welstead G.G., Zaidi S., Gokhale S., Scholer H.R., Tomilin A., Jaenisch R. Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 2007, 1:403-415.
38. Li G., Zhang X.A., Wang H., Wang X., Meng C.L., Chan C.Y., Yew D.T., Tsang K.S., Li K., Tsai S.N., Ngai S.M., Han Z.C., Lin M.C., He M.L., Kung H.F. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteomics 2009, 9:20-30.
39. Lin Q., Schwarz J., Bucana C., Olson E.N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997, 276:1404-1407.
40. Mankoo B.S., Skuntz S., Harrigan I., Grigorieva E., Candia A., Wright C.V., Arnheiter H., Pachnis V. The concerted action of Meox homeobox genes is required upstream of genetic pathways essential for the formation, patterning and differentiation of somites. Development 2003, 130:4655-4664.
41. Menicanin D., Bartold P.M., Zannettino A.C., Gronthos S. Genomic profiling of mesenchymal stem cells. Stem Cell Rev. 2009, 5:36-50.
42. Miyazaki T., Muller U., Campbell K.S. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J. 1997, 16:4217-4225.
43. Montesinos J.J., Flores-Figueroa E., Castillo-Medina S., Flores-Guzman P., Hernandez-Estevez E., Fajardo-Orduna G., Orozco S., Mayani H. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Cytotherapy 2009, 11:163-176.
44. Muller F.J., Laurent L.C., Kostka D., Ulitsky I., Williams R., Lu C., Park I.H., Rao M.S., Shamir R., Schwartz P.H., Schmidt N.O., Loring J.F. Regulatory networks define phenotypic classes of human stem cell lines. Nature 2008, 455:401-405.
45. Naiche L.A., Papaioannou V.E. Tbx4 is not required for hindlimb identity or post-bud hindlimb outgrowth. Development 2007, 134:93-103.
46. Noel D., Caton D., Roche S., Bony C., Lehmann S., Casteilla L., Jorgensen C., Cousin B. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp. Cell Res. 2008, 314:1575-1584.
47. Oliver J.A., Maarouf O., Cheema F.H., Martens T.P., Al-Awqati Q. The renal papilla is a niche for adult kidney stem cells. J. Clin. Investig. 2004, 114:795-804.
48. Patschan D., Michurina T., Shi H.K., Dolff S., Brodsky S.V., Vasilieva T., Cohen-Gould L., Winaver J., Chander P.N., Enikolopov G., Goligorsky M.S. Normal distribution and medullary-to-cortical shift of Nestin-expressing cells in acute renal ischemia. Kidney Int. 2007, 71:744-754.
49. Pennisi D.J., Wilkinson L., Kolle G., Sohaskey M.L., Gillinder K., Piper M.J., McAvoy J.W., Lovicu F.J., Little M.H. Crim1KST264/KST264 mice display a disruption of the Crim1 gene resulting in perinatal lethality with defects in multiple organ systems. Dev. Dyn. 2007, 236:502-511.
50. Phinney D.G., Hill K., Michelson C., DuTreil M., Hughes C., Humphries S., Wilkinson R., Baddoo M., Bayly E. Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy. Stem Cells 2006, 24:186-198.
51. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
52. Riekstina U., Cakstina I., Parfejevs V., Hoogduijn M., Jankovskis G., Muiznieks I., Muceniece R., Ancans J. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev. 2009, 5:378-386.
53. Ries C., Egea V., Karow M., Kolb H., Jochum M., Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 2007, 109:4055-4063.
54. Roubelakis M.G., Pappa K.I., Bitsika V., Zagoura D., Vlahou A., Papadaki H.A., Antsaklis A., Anagnou N.P. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev. 2007, 16:931-952.
55. Sarugaser R., Lickorish D., Baksh D., Hosseini M.M., Davies J.E. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005, 23:220-229.
56. Skuntz S., Mankoo B., Nguyen M.T., Hustert E., Nakayama A., Tournier-Lasserve E., Wright C.V., Pachnis V., Bharti K., Arnheiter H. Lack of the mesodermal homeodomain protein MEOX1 disrupts sclerotome polarity and leads to a remodeling of the cranio-cervical joints of the axial skeleton. Dev. Biol. 2009, 332:383-395.
57. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. Article3.
58. Smyth G.K. Limma: Linear Models For Microarray Data, eds. Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005, 397-420. Springer, New York.
59. Steigman S.A., Fauza D.O. Isolation of mesenchymal stem cells from amniotic fluid and placenta. Curr. Protoc. Stem Cell Biol. 2007, 1:1E.2.1-1E.2.12.
60. Sundberg C., Kowanetz M., Brown L.F., Detmar M., Dvorak H.F. Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab. Investig. 2002, 82:387-401.
61. Tilton R.G. Capillary pericytes: perspectives and future trends. J. Electron Microsc. Tech. 1991, 19:327-344.
62. Tondreau T., Meuleman N., Stamatopoulos B., De Bruyn C., Delforge A., Dejeneffe M., Martiat P., Bron D., Lagneaux L. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy 2009, 11:559-569.
63. Tsai M.S., Hwang S.M., Chen K.D., Lee Y.S., Hsu L.W., Chang Y.J., Wang C.N., Peng H.H., Chang Y.L., Chao A.S., Chang S.D., Lee K.D., Wang T.H., Wang H.S., Soong Y.K. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 2007, 25:2511-2523.
64. Wagner W., Wein F., Seckinger A., Frankhauser M., Wirkner U., Krause U., Blake J., Schwager C., Eckstein V., Ansorge W., Ho A.D. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 2005, 33:1402-1416.
65. Wang S.S., Asfaha S., Okumura T., Betz K.S., Muthupalani S., Rogers A.B., Tu S., Takaishi S., Jin G., Yang X., Wu D.C., Fox J.G., Wang T.C. Fibroblastic colony-forming unit bone marrow cells delay progression to gastric dysplasia in a helicobacter model of gastric tumorigenesis. Stem Cells 2009, 27:2301-2311.
66. Wiese C., Rolletschek A., Kania G., Blyszczuk P., Tarasov K.V., Tarasova Y., Wersto R.P., Boheler K.R., Wobus A.M. Nestin expression-a property of multi-lineage progenitor cells?. Cell. Mol. Life Sci. 2004, 61:2510-2522.
67. Xu G., Zhang Y., Zhang L., Ren G., Shi Y. Bone marrow stromal cells induce apoptosis of lymphoma cells in the presence of IFNgamma and TNF by producing nitric oxide. Biochem. Biophys. Res. Commun. 2008, 375:666-670.
68. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., Naito M., Nakao K. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408:92-96.
69. Yan X., Qin H., Qu C., Tuan R.S., Shi S., Huang G.T. iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev. 2009, 19:469-480.
70. Zhang Z.Y., Teoh S.H., Chong M.S., Schantz J.T., Fisk N.M., Choolani M.A., Chan J. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 2009, 27:126-137.